Human papillomavirus vaccines developed by Escherichia coli expression system: progress and perspectives from China
Cervical cancer remains a major global public health threat, disproportionately affecting low-income and middle-income countries (LMICs). Prophylactic human papillomavirus (HPV) vaccination is a cornerstone of its prevention but traditional eukaryotic expression systems limit accessibility due to high costs and compl...